Clinical Trial Update: Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with epacadostat in thymic carcinoma to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymus Neoplasms

Drugs mentioned

• Epacadostat (epacadostat)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Georgetown University | Conditions: Thymic Carcinoma, Thymus Neoplasms | Phase 2 | Status: UNKNOWN | Results posted: 2019-12-13